These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35649342)

  • 1. BETA: a comprehensive benchmark for computational drug-target prediction.
    Zong N; Li N; Wen A; Ngo V; Yu Y; Huang M; Chowdhury S; Jiang C; Fu S; Weinshilboum R; Jiang G; Hunter L; Liu H
    Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35649342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug Repurposing.
    Lim H; Poleksic A; Yao Y; Tong H; He D; Zhuang L; Meng P; Xie L
    PLoS Comput Biol; 2016 Oct; 12(10):e1005135. PubMed ID: 27716836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. iDrug: Integration of drug repositioning and drug-target prediction via cross-network embedding.
    Chen H; Cheng F; Li J
    PLoS Comput Biol; 2020 Jul; 16(7):e1008040. PubMed ID: 32667925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TeM-DTBA: time-efficient drug target binding affinity prediction using multiple modalities with Lasso feature selection.
    Liyaqat T; Ahmad T; Saxena C
    J Comput Aided Mol Des; 2023 Dec; 37(12):573-584. PubMed ID: 37777631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DeepSeq2Drug: An expandable ensemble end-to-end anti-viral drug repurposing benchmark framework by multi-modal embeddings and transfer learning.
    Xie W; Yu J; Huang L; For LS; Zheng Z; Chen X; Wang Y; Liu Z; Peng C; Wong KC
    Comput Biol Med; 2024 Jun; 175():108487. PubMed ID: 38653064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep learning prediction of chemical-induced dose-dependent and context-specific multiplex phenotype responses and its application to personalized alzheimer's disease drug repurposing.
    Wu Y; Liu Q; Qiu Y; Xie L
    PLoS Comput Biol; 2022 Aug; 18(8):e1010367. PubMed ID: 35951653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tripartite Network-Based Repurposing Method Using Deep Learning to Compute Similarities for Drug-Target Prediction.
    Zong N; Wong RSN; Ngo V
    Methods Mol Biol; 2019; 1903():317-328. PubMed ID: 30547451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of network-based approaches and machine learning algorithms for predicting drug-target interactions.
    Jung YS; Kim Y; Cho YR
    Methods; 2022 Feb; 198():19-31. PubMed ID: 34737033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing in silico drug discovery: simulation of connected differential expression signatures and applications to benchmarking.
    Gonzalez Gomez C; Rosa-Calatrava M; Fouret J
    Brief Bioinform; 2024 May; 25(4):. PubMed ID: 38935068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BindingSite-AugmentedDTA: enabling a next-generation pipeline for interpretable prediction models in drug repurposing.
    Yousefi N; Yazdani-Jahromi M; Tayebi A; Kolanthai E; Neal CJ; Banerjee T; Gosai A; Balasubramanian G; Seal S; Ozmen Garibay O
    Brief Bioinform; 2023 May; 24(3):. PubMed ID: 37096593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-target prediction utilizing heterogeneous bio-linked network embeddings.
    Zong N; Wong RSN; Yu Y; Wen A; Huang M; Li N
    Brief Bioinform; 2021 Jan; 22(1):568-580. PubMed ID: 31885036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico drug repositioning based on integrated drug targets and canonical correlation analysis.
    Chen H; Zhang Z; Zhang J
    BMC Med Genomics; 2022 Mar; 15(1):48. PubMed ID: 35249529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomedical data and computational models for drug repositioning: a comprehensive review.
    Luo H; Li M; Yang M; Wu FX; Li Y; Wang J
    Brief Bioinform; 2021 Mar; 22(2):1604-1619. PubMed ID: 32043521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DEDTI versus IEDTI: efficient and predictive models of drug-target interactions.
    Zabihian A; Sayyad FZ; Hashemi SM; Shami Tanha R; Hooshmand M; Gharaghani S
    Sci Rep; 2023 Jun; 13(1):9238. PubMed ID: 37286613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational Drug Repositioning: A Lateral Approach to Traditional Drug Discovery?
    Sahu NU; Kharkar PS
    Curr Top Med Chem; 2016; 16(19):2069-77. PubMed ID: 26881717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-target interaction prediction: A Bayesian ranking approach.
    Peska L; Buza K; Koller J
    Comput Methods Programs Biomed; 2017 Dec; 152():15-21. PubMed ID: 29054256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Machine Learning Approach for Drug-target Interaction Prediction using Wrapper Feature Selection and Class Balancing.
    Redkar S; Mondal S; Joseph A; Hareesha KS
    Mol Inform; 2020 May; 39(5):e1900062. PubMed ID: 32003548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SDTNBI: an integrated network and chemoinformatics tool for systematic prediction of drug-target interactions and drug repositioning.
    Wu Z; Cheng F; Li J; Li W; Liu G; Tang Y
    Brief Bioinform; 2017 Mar; 18(2):333-347. PubMed ID: 26944082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDeePred: novel multi-channel protein featurization for deep learning-based binding affinity prediction in drug discovery.
    Rifaioglu AS; Cetin Atalay R; Cansen Kahraman D; Doğan T; Martin M; Atalay V
    Bioinformatics; 2021 May; 37(5):693-704. PubMed ID: 33067636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dex-Benchmark: datasets and code to evaluate algorithms for transcriptomics data analysis.
    Xie Z; Chen C; Ma'ayan A
    PeerJ; 2023; 11():e16351. PubMed ID: 37953774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.